CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
256-270 of 1225
EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
MinuteCE®EGFR-Mutated NSCLC With Brain Metastases: Navigating ADC Treatment Decisions
Benjamin Levy, MD
Melin Khandekar, MD, PhD
Diagnostic Challenges in Refractory Chronic Cough: From Burden to Solutions
CME/CEDiagnostic Challenges in Refractory Chronic Cough: From Burden to Solutions
Sandhya Khurana, MD, FCCP
Syed Shahzad Mustafa, MD
Ashley Wilk, DO, DipABLM
Rethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
CME/CERethinking Secondary Stroke Prevention: The Emerging Role of Factor XI Inhibition
Mukul Sharma, MD, MSc, FRCPC
Ashkan Shoamanesh, MD, MSc, FRCPC
DKA in the Real World: Evidence and Cases that Matter
CME/CEDKA in the Real World: Evidence and Cases that Matter
Carol Wysham, MD
Samuel Seidu, MD, FRCP(Edin), FRCGP
Understanding the Microbiome’s Role in IBD Management
MinuteCE®Understanding the Microbiome’s Role in IBD Management
Florence Odufalu, MD
David T. Rubin, MD
Ugo Iroku, MD, MHS
- advertisement
David T. Rubin, MD
Michael Dolinger, MD, MBA
Florence Odufalu, MD
Ugo Iroku, MD, MHS
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Beyond Biology: Environmental and Lifestyle Influences in IBD
MinuteCE®Beyond Biology: Environmental and Lifestyle Influences in IBD
Sharon Dudley-Brown, PhD, FNP-BC, FAAN, FAANP
Florence Odufalu, MD
IBD Beyond Symptoms: What Community GIs Need to Know
MinuteCE®IBD Beyond Symptoms: What Community GIs Need to Know
David T. Rubin, MD
Ugo Iroku, MD, MHS
Florence Odufalu, MD
Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
MinuteCE®Genetic Susceptibility in IBD: From Risk Genes to Clinical Impact
Michael Dolinger, MD, MBA
Targeting Inflammation in IBD: Localized vs Systemic Strategies
MinuteCE®Targeting Inflammation in IBD: Localized vs Systemic Strategies
David T. Rubin, MD
Michael Dolinger, MD, MBA
- advertisement
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
CME/CENavigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, MRCP, PhD
Claudia Seikrit, MD
Optimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
NephrologyOptimizing Iron Deficiency Management in CKD: IV Iron Replacement Therapy Amid the Latest KDIGO Guidelines
Brendon Neuen, MBBS, PhD
Calming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
CME/CECalming Overactive Immune Response and Reducing Inflammation with TYK2 Inhibition in Psoriasis
April W. Armstrong, MD, MPH
Melinda Gooderham, MSc, MD, FRCPC
